Over the last 12 months, Incyte insiders reported no purchases and 9 sales totaling $13.2M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | CAGNONI PABLO JPresident, Global Head of R&D · O | ▼ Sale | 10,640 | $122.69 | $1.3M | -4.9% | plan |
| Aug 5, 2026 | Mayes Patrick AEVP & Chief Scientific Officer · O | ▼ Sale | 2,207 | $123.99 | $274K | -3.5% | plan |
| Aug 3, 2026 | Mayes Patrick AEVP & Chief Scientific Officer · O | ▼ Sale | 47,954 | $119.58 | $5.7M | -43.8% | plan · 12 tranches |
| Jul 31, 2026 | CAGNONI PABLO JPresident, Global Head of R&D · O | ▼ Sale | 15,888 | $119.7 | $1.9M | -6.9% | plan |
| Jul 16, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. · O | ▼ Sale | 1,877 | $114.73 | $215K | -8.2% | plan |
| Jul 16, 2026 | Issa Mohamed KhairieEVP, Head of U.S. Commercial · O | ▼ Sale | 1,093 | $115.01 | $126K | -1.7% | plan |
| Jul 15, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. · O | ▼ Sale | 28,237 | $113.05 | $3.2M | -52% | plan |
| Jun 4, 2026 | Tray ThomasPrincipal Accounting Officer · O | ▼ Sale | 2,639 | $100 | $264K | -11.1% | plan |
| May 26, 2026 | Tray ThomasPrincipal Accounting Officer · O | ▼ Sale | 2,051 | $97.35 | $200K | -8.8% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $INCY feed.